47045-SDN-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>HIV/AIDS - Tuberculosis - Sudan (01-Jan-2024-31-Dec-2026)</narrative> Sudan, Multicomponent, United Nations Development Programme Goal: To ensure continuation of essential TB and HIV services during the Sudan Emergency situation 2024-2026. Objectives: Coverage of quality ART services increased from 22.5% in 2023 to 28% in 2026; Coverage of key populations with the integrated package of preventive and treatment services increased from 57% (MSM) and 38%(FSWs) in 2022 to 60% in 2026 (Both MSM and FSW); To increase TB treatment success rate from 83% in 2022 to 90% in 2026; To increase the detection of MDR/RR-TB from 135 in 2022 to 198 by 2026 and the treatment success rate from 73% in 2022 to 86% in 2026; To strengthen and upgrade the capacities of TB laboratory network; to maintain at least 183 functional microscopy centers, 1 culture zonal laboratories and to expand the number of GeneXpert sites to 60 by 2026. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Noah Zahrobsky Fund Portfolio Manager +41 58 791 1700 noah.zahrobsky@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Sudan Multicomponent, RSSH HIV Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Pre-exposure prophylaxis (PrEP) programming for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP HIV -> Prevention package for people in prisons and other closed settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health products management systems -> Storage and distribution capacity, design & operations RSSH -> RSSH: Health products management systems -> Supply chain information systems RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Operational Research RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Others Tuberculosis -> Removing human rights and gender related barriers to TB services -> Ensuring people-centered and rights-based TB services at health facilities Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection Tuberculosis -> TB/HIV -> TB/HIV - Prevention Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis 8239082.90 12570434.76 10364133.37 17169271.07 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6269706.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5534272.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4931393.53 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4576808.00 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -433899.54 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2465099.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -2111709.00 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 9455709.00 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5816717.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3498672.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4248973.00 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -140320.00 Global Fund commitment to SDN-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3588662.00 Global Fund disbursement to SDN-C-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8239083.00 Expenditure reported by United Nations Development Programme for SDN-C-UNDPP01, Jan 2024 to Dec 2024. United Nations Development Programme 12053907.00 Expenditure reported by United Nations Development Programme for SDN-C-UNDPP01, Jan 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 3 - TB/HIV - Sudan - English</narrative> Funding Request of funding request FR1524-SDN-C. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 28311; Denominator: 52484. Numerator: 1967.2; Denominator: 12294. Numerator: 3934.4; Denominator: 12294. Numerator: 3934.4; Denominator: 12294. Numerator: 5044.8; Denominator: 12611. Numerator: 1496; Denominator: 12611. Numerator: 2522.4; Denominator: 12611. Numerator: 5044.8; Denominator: 12611. Numerator: 1496; Denominator: 12611. Numerator: 3087.2; Denominator: 12863. Numerator: 6174.4; Denominator: 12863. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 28463; Denominator: 80380. Numerator: 3316; Denominator: 20725. Numerator: 6632; Denominator: 20725. Numerator: 6632; Denominator: 20725. Numerator: 8502.4; Denominator: 21256. Numerator: 2283; Denominator: 21256. Numerator: 4251.2; Denominator: 21256. Numerator: 8502.4; Denominator: 21256. Numerator: 2283; Denominator: 21256. Numerator: 5228.8; Denominator: 21787. Numerator: 10457.6; Denominator: 21787. <narrative>DRTB-2-Other: Number of women with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>DRTB-2-Other: Number of women with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 135. Percentage: 93.85%. Percentage: 93.85%. Numerator: 114; Denominator: 114; Percentage: 100%. Numerator: 98; Denominator: 101; Percentage: 97.03%. Numerator: 57; Denominator: 57; Percentage: 100%. Numerator: 57; Denominator: 57; Percentage: 100%. Numerator: 65; Denominator: 62; Percentage: 104.84%. Numerator: 98. Numerator: 148; Denominator: 148; Percentage: 100%. Numerator: 144; Denominator: 159; Percentage: 90.57%. Numerator: 74; Denominator: 74; Percentage: 100%. Numerator: 74; Denominator: 74; Percentage: 100%. Numerator: 85; Denominator: 93; Percentage: 91.4%. Numerator: 144. Numerator: 99; Denominator: 99; Percentage: 100%. Numerator: 99; Denominator: 99; Percentage: 100%. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 30058; Denominator: 52484. Numerator: 4918; Denominator: 12294. Numerator: 2459; Denominator: 12294. Numerator: 4918; Denominator: 12294. Numerator: 6306; Denominator: 12611. Numerator: 1532; Denominator: 12611. Numerator: 3153; Denominator: 12611. Numerator: 6306; Denominator: 12611. Numerator: 1532; Denominator: 12611. Numerator: 3859; Denominator: 12863. Numerator: 7718; Denominator: 12863. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention package for sex workers, their clients and other sexual partners. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 30886; Denominator: 80380. Numerator: 4145; Denominator: 20725. Numerator: 8290; Denominator: 20725. Numerator: 8290; Denominator: 20725. Numerator: 5314; Denominator: 21256. Numerator: 10628; Denominator: 21256. Numerator: 2381; Denominator: 21256. Numerator: 10628; Denominator: 21256. Numerator: 2381; Denominator: 21256. Numerator: 6536; Denominator: 21787. Numerator: 13072; Denominator: 21787. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 1487; Denominator: 2370. Numerator: 3318; Denominator: 4740. Numerator: 1168; Denominator: 2364. Numerator: 1659; Denominator: 2370. Numerator: 1659; Denominator: 2370. Numerator: 442; Denominator: 1146. Numerator: 1896; Denominator: 2370. Numerator: 3792; Denominator: 4740. Numerator: 2229; Denominator: 2390. Numerator: 1896; Denominator: 2370. Numerator: -99; Denominator: 37. Numerator: 2370; Denominator: 2370. Numerator: 2370; Denominator: 2370. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 1168; Denominator: 1552; Percentage: 75.26%. Percentage: 73.42%. Percentage: 73.42%. Percentage: 0.26%. Percentage: 0.26%. Percentage: 75%. Percentage: 75%. Percentage: 81.53%. Percentage: 81.53%. Numerator: 1009; Denominator: 1659; Percentage: 60.82%. Numerator: 2018; Denominator: 3318; Percentage: 60.8%. Numerator: 1082; Denominator: 1168; Percentage: 92.64%. Numerator: 1009; Denominator: 1659; Percentage: 60.82%. Numerator: 593; Denominator: 442; Percentage: 134.16%. Numerator: 630; Denominator: 716; Percentage: 87.99%. Numerator: 20; Denominator: 20; Percentage: 100%. Numerator: 1062; Denominator: 1148; Percentage: 92.51%. Numerator: 452; Denominator: 452; Percentage: 100%. Numerator: 2328; Denominator: 3448; Percentage: 67.5%. Numerator: 2095; Denominator: 2229; Percentage: 93.99%. Numerator: 1164; Denominator: 1896; Percentage: 61.39%. Numerator: 1164; Denominator: 1552; Percentage: 75%. Numerator: 125; Denominator: -124; Percentage: -100.81%. Numerator: 1451; Denominator: 1533; Percentage: 94.65%. Numerator: 0; Denominator: 0. Numerator: 2095; Denominator: 2334; Percentage: 89.76%. Numerator: 644; Denominator: 696; Percentage: 92.53%. Numerator: 1319; Denominator: 1552; Percentage: 84.99%. Numerator: 1319; Denominator: 1552; Percentage: 84.99%. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 19235. Percentage: 90.37%. Percentage: 90.37%. Percentage: 9.63%. Percentage: 9.63%. Numerator: 3575; Denominator: 9075; Percentage: 39.39%. Numerator: 3575; Denominator: 9075; Percentage: 39.39%. Percentage: 28.11%. Percentage: 28.11%. Percentage: 71.29%. Percentage: 71.29%. Numerator: 6651. Numerator: 13302. Numerator: 13494. Numerator: 6651. Numerator: 7393. Numerator: 12176. Numerator: 1318. Numerator: 9718. Numerator: 2937. Numerator: 10421. Numerator: 7362.5. Numerator: 14725. Numerator: 23554. Numerator: 7362.5. Numerator: 13079. Numerator: 21266. Numerator: 2288. Numerator: 15727. Numerator: 7318. Numerator: 16134. Numerator: 8112. Numerator: 8112. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 3042; Denominator: 9075. Numerator: 5076; Denominator: 13302. Numerator: 6367; Denominator: 13494. Numerator: 2538; Denominator: 6651. Numerator: 2538; Denominator: 6651. Numerator: 5614; Denominator: 7393. Numerator: 6306; Denominator: 14725. Numerator: 7453; Denominator: 23554. Numerator: 3153; Denominator: 7362.5. Numerator: 3153; Denominator: 7362.5. Numerator: 4716; Denominator: 13079. Numerator: 3873; Denominator: 8112. Numerator: 3872.5; Denominator: 8112. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 7525; Denominator: 9091. Numerator: 5320.5; Denominator: 6651. Numerator: 10641; Denominator: 13302. Numerator: 8435; Denominator: 13280. Numerator: 5320.5; Denominator: 6651. Numerator: 4857; Denominator: 5886. Numerator: 12222; Denominator: 14725. Numerator: 13223; Denominator: 14987. Numerator: 6111; Denominator: 7362.5. Numerator: 6111; Denominator: 7362.5. Numerator: 7466; Denominator: 8518. Numerator: 6976.5; Denominator: 8112. Numerator: 6976.5; Denominator: 8112. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 53; Denominator: 54. Numerator: 124; Denominator: 126.4. Numerator: 109; Denominator: 136. Numerator: 62.02; Denominator: 63.18. Numerator: 62.02; Denominator: 63.18. Numerator: 44; Denominator: 66. Numerator: 68.65; Denominator: 69.94. Numerator: 137.2; Denominator: 139.8. Numerator: 95; Denominator: 102. Numerator: 68.65; Denominator: 69.94. Numerator: 55; Denominator: 55. Numerator: 77.06; Denominator: 77.06. Numerator: 77.06; Denominator: 77.06. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 38; Denominator: 10744. Numerator: 38; Denominator: 10744. Numerator: 0; Denominator: 1411. Numerator: 0; Denominator: 1411. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 992; Denominator: 992. Numerator: 1179; Denominator: 1212. Numerator: 714; Denominator: 701. Numerator: 1749; Denominator: 1749. Numerator: 1014; Denominator: 1014. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 623; Denominator: 5177; Percentage: 12.03%. Percentage: 5.54%. Percentage: 5.54%. Percentage: 6.49%. Percentage: 6.49%. Numerator: 636; Denominator: 5289; Percentage: 12.02%. Numerator: 680; Denominator: 5289; Percentage: 12.9%. Numerator: 312; Denominator: 4600; Percentage: 6.78%. Numerator: 680; Denominator: 5289; Percentage: 12.86%. Numerator: 312; Denominator: 4600; Percentage: 6.78%. Numerator: 142. Numerator: 170. Numerator: 722; Denominator: 5537; Percentage: 13.04%. Numerator: 764; Denominator: 5537; Percentage: 13.8%. Numerator: 342; Denominator: 4000; Percentage: 8.55%. Numerator: 764; Denominator: 5537; Percentage: 13.8%. Numerator: 342; Denominator: 4000; Percentage: 8.55%. Numerator: 150; Denominator: 342; Percentage: 43.86%. Numerator: 193; Denominator: 342; Percentage: 56.43%. Numerator: 837; Denominator: 5886; Percentage: 14.22%. Numerator: 910; Denominator: 5886; Percentage: 15.46%. <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 1077; Denominator: 10744. Numerator: 1077; Denominator: 10744. Numerator: 1842; Denominator: 11899. Numerator: 1842; Denominator: 11899. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 9741; Denominator: 43268. Numerator: 10002; Denominator: 45495. Numerator: 10263; Denominator: 45495. Numerator: 10744; Denominator: 48000. Numerator: 10263; Denominator: 45495. Numerator: 10744; Denominator: 48000. Numerator: 11710; Denominator: 47971. Numerator: 11899; Denominator: 54000. Numerator: 10986.5; Denominator: 47971. Numerator: 11710; Denominator: 47971. Numerator: 11899; Denominator: 54000. Numerator: 12984.5; Denominator: 50743. Numerator: 14259; Denominator: 50743.